Related Experiment Video
Updated: May 1, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Chemokines as potential markers in pediatric renal diseases
Ana Cristina Simões e Silva1, André Barreto Pereira2, Mauro Martins Teixeira3
1Unidade de Nefrologia Pediátrica, Departamento de Pediatria, Universidade Federal de Minas Gerais (UFMG), 30130-100 Belo Horizonte, MG, Brazil ; Instituto Nacional de Ciência e Tecnologia em Medicina Molecular (INCT-MM), Faculdade de Medicina, UFMG, 30130-100 Belo Horizonte, MG, Brazil ; Laboratório Interdisciplinar de Investigação Médica Faculdade de Medicina, UFMG, Avenida Alfredo Balena 190, 2nd Floor, Room No.281, 30130-100 Belo Horizonte, MG, Brazil.
Insights
Chemokines show promise as biomarkers for diagnosing pediatric kidney diseases. Evaluating these inflammatory molecules may aid in managing childhood renal diseases and identifying those at risk for chronic kidney disease (CKD).
Area of Science:
- Pediatric Nephrology
- Renal Pathophysiology
- Biomarker Discovery
Background:
- Chronic kidney disease (CKD) in children is frequently caused by glomerular diseases and obstructive uropathies.
- Biomarkers are increasingly researched for diagnosing pediatric renal conditions.
- Chemokines are inflammatory mediators implicated in the pathophysiology of various pediatric renal diseases.
Purpose of the Study:
- To review general aspects of chemokines.
- To explore the potential link between chemokines and common pediatric renal diseases.
- To synthesize experimental and clinical evidence regarding chemokines in pediatric kidney disease.
Main Methods:
- Literature review of chemokines.
- Analysis of experimental data on chemokines in renal disease models.
- Examination of clinical studies investigating chemokines in pediatric patients with kidney diseases.
Main Results:
- Chemokines play significant roles in the development and progression of pediatric renal diseases.
- Specific chemokines may serve as valuable diagnostic or prognostic markers.
- Evidence suggests chemokines are involved in the inflammatory processes underlying common childhood kidney conditions.
Conclusions:
- Chemokines represent a promising class of biomarkers for pediatric renal diseases.
- Further research into chemokines could improve diagnosis, risk stratification, and management of CKD in children.
- Evaluating chemokine profiles may offer new therapeutic targets for pediatric kidney disorders.
Abstract:
Glomerular diseases and obstructive uropathies are the two most frequent causes of chronic kidney disease (CKD) in children. Recently, biomarkers have become a focus of clinical research as potentially useful diagnostic tools in pediatric renal diseases. Among several putative biomarkers, chemokines emerge as promising molecules since they play relevant roles in the pathophysiology of pediatric renal diseases. The evaluation of these inflammatory mediators might help in the management of diverse renal diseases in children and the detection of patients at high risk to develop CKD. The aim of this paper is to revise general aspects of chemokines and the potential link between chemokines and the most common pediatric renal diseases by including experimental and clinical evidence.
More Related Videos
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
05:39Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate